glp-1 and liver cirrhosis Frontiers The weight-loss-independent hepatoprotective benefits of
Description
WHERE ARE THEY THESE DAYS
doi: 10.1146/annurev-genom-083115-022438 105 KohlerS.ThomasA
Gearhardt and DiFeliceantonio, 2023)
Gastrointestinal side effects remain one of the most significant challenges associated with many currently marketed GLP-1 therapies and are a major factor affecting long-term patient adherence
Early intervention, particularly for those not responding well to initial treatments, can more than double weight loss outcomes
McIntyre N, Holdsworth CD, and Turner DS
